# MAC vs TIVA Ambulatory Breast Augmentation

> **NCT03764267** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Breast Diseases

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** general anesthetic

## Key facts

- **NCT ID:** NCT03764267
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2017-01-01
- **Final completion:** 2018-01-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764267, "MAC vs TIVA Ambulatory Breast Augmentation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03764267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*